Toxicological aspects of topical silver pharmaceuticals.
about
Topical silver for treating infected woundsSilver Nanoparticles: Technological Advances, Societal Impacts, and Metrological Challenges.Acute and subchronic dermal toxicity of nanosilver in guinea pigApplication of Hyperosmotic Nanoemulsions in Wound Healing: Partial Thickness Injury Model in Swine.Metals and kidney autoimmunity.A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity.Enhanced transparency, mechanical durability, and antibacterial activity of zinc nanoparticles on glass substrate.A comparative study of the burn wound healing properties of saline-soaked dressing and silver sulfadiazine in ratsExposure of human proximal tubule cells to cd2+, zn2+, and Cu2+ induces metallothionein protein accumulation but not metallothionein isoform 2 mRNA.Incidence of embolism and paravalvar leak after St Jude Silzone valve implantation: experience from the Cardiff Embolic Risk Factor Study.Investigating the pharmacokinetics and biological distribution of silver-loaded polyphosphoester-based nanoparticles using (111) Ag as a radiotracer.How safe is silver in wound care?A review of the use of silver in wound care: facts and fallacies.The influence of elementary silver versus titanium on osteoblasts behaviour in vitro using human osteosarcoma cell lines.Silver-Containing Hydroxyapatite Coating Reduces Biofilm Formation by Methicillin-Resistant Staphylococcus aureus In Vitro and In Vivo.Silver toxicity with the use of silver-impregnated dressing and wound vacuum-assisted closure in an immunocompromised patient.The use of 111Ag as a tool for studying biological distribution of silver-based antimicrobials.Acute and subacute toxicity in vivo of thermal-sprayed silver containing hydroxyapatite coating in rat tibiaA novel hydroxyapatite film coated with ionic silver via inositol hexaphosphate chelation prevents implant-associated infection.Nondermal irritating hyperosmotic nanoemulsions reduce treatment times in a contamination model of wound healing.Silver nanoparticle deposited implants to treat osteomyelitis.Evaluation of osseous integration of PVD-silver-coated hip prostheses in a canine model.An in vivo comparison of commonly used topical antimicrobials on skin graft healing after full-thickness burn injury.A novel in vitro metric predicts in vivo efficacy of inhaled silver-based antimicrobials in a murine Pseudomonas aeruginosa pneumonia model.Silver and its application as an antimicrobial agentClinical Outcomes for Diabetic Foot Ulcers Treated with Clostridial Collagenase Ointment or with a Product Containing Silver
P2860
Q24246210-D170C2F5-7B1D-4665-8D8A-06891670E09EQ29248033-81803016-56E3-4824-AA90-B320BEB640DFQ29248687-4F49A380-2308-4BB9-B120-7D2B9A125C2AQ33647670-5FE205D6-630A-44C2-9798-7664B94AAC54Q33741203-3D621821-84C3-4F32-A712-9522262CC0ABQ34096546-115A02FC-72C7-4C3F-907F-D43CBE49C2A0Q34124474-EFC41408-CF6D-4255-A4DA-7630221E6825Q34796949-A351D235-96A0-4182-AE46-E7F9DAECEB88Q34938805-7C05C8C9-6FCF-4650-A2F1-75186A9EB603Q35581560-F2745031-30A0-468F-AC20-4970E3E2727EQ35688572-58A84147-8154-4718-B6B4-3368BE8B5025Q35758920-546C7FB1-5A53-41DC-9B54-0F1737D8A1F7Q35764486-E5E0FE95-E96C-45CB-9C41-3335848E6320Q35894720-BDBADBA5-1345-4F4D-BA46-0DA275296BA1Q36254860-A84A26DD-E17C-4DA7-8E83-ACDE525F50F1Q36697587-0006562C-3208-42D9-A8FE-3F155AB7B6BDQ37069963-B7CAAB5F-7157-4FE7-BDDA-CA428CFCBD8AQ37687926-0A1B2C4C-C4B4-429B-A92D-48C38B7D7E59Q38785715-9DEFA44E-BB9D-4145-8C73-1179C42592F4Q39841780-2EE87072-4ABC-42E9-80F4-E718C6704B73Q40210960-04C99EF6-680D-43DA-B914-D2357F742F12Q41475851-CA421753-E62E-4DAF-ACE4-E3C23803F584Q44408384-59B14B5C-6889-4FCF-86A0-3EF135CDA3F1Q52568549-2EB18580-B8A3-4DF5-9AD1-153CA674C81BQ57381719-AD7E6B75-7810-4B7F-9E1E-8C7ADD6CE6C5Q58124101-1EA3C00F-C66F-44D6-8163-4E539FD9C956
P2860
Toxicological aspects of topical silver pharmaceuticals.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Toxicological aspects of topical silver pharmaceuticals.
@en
type
label
Toxicological aspects of topical silver pharmaceuticals.
@en
prefLabel
Toxicological aspects of topical silver pharmaceuticals.
@en
P2860
P1476
Toxicological aspects of topical silver pharmaceuticals.
@en
P2093
Hollinger MA
P2860
P304
P356
10.3109/10408449609012524
P407
P577
1996-05-01T00:00:00Z